| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
14,410,000 |
| Market
Cap: |
4.80(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3333 - $0.3333 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
85,262 |
| Total Buy Value |
$0 |
$0 |
$0 |
$197,404 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Selby Brian L. |
VP, Finance |
• – – |
2015-03-02 |
4 |
AS |
$0.71 |
$800 |
D/D |
(1,125) |
33,441 |
|
- |
|
| Ozeroff Christopher David |
S.V.P., General Counsel |
• – – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,050 |
150,787 |
|
- |
|
| Keuer Thomas A |
Chief Operating Officer |
• – – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,350 |
126,626 |
|
- |
|
| Bristow Michael R |
President and CEO |
• • – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
48,100 |
340,725 |
|
- |
|
| Selby Brian L. |
VP, Finance |
• – – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
23,400 |
34,566 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2015-01-16 |
4 |
S |
$0.75 |
$75,000 |
I/I |
(100,000) |
2,100,000 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2015-01-15 |
4 |
S |
$0.75 |
$93,750 |
I/I |
(125,000) |
2,200,000 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2015-01-14 |
4 |
S |
$0.79 |
$98,750 |
I/I |
(125,000) |
2,325,000 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2015-01-07 |
4 |
S |
$0.87 |
$174,000 |
I/I |
(200,000) |
2,450,000 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2015-01-06 |
4 |
S |
$0.92 |
$184,000 |
I/I |
(200,000) |
2,650,000 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2015-01-05 |
4 |
S |
$0.97 |
$145,500 |
I/I |
(150,000) |
2,850,000 |
|
- |
|
| Selby Brian L. |
VP, FinanceOfficer |
• – – |
2014-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,166 |
|
- |
|
| Keuer Thomas A |
Chief Operating OfficerOfficer |
• – – |
2014-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
101,276 |
|
- |
|
| Bristow Michael R |
President and CEO |
• • – |
2014-09-18 |
4 |
AS |
$1.30 |
$18,009 |
D/D |
(13,853) |
292,625 |
|
- |
|
| Wheeler Patrick M |
Chief Financial Officer |
• – – |
2014-09-18 |
4 |
AS |
$1.31 |
$10,802 |
D/D |
(8,246) |
101,510 |
|
- |
|
| Bristow Michael R |
President and CEO |
• • – |
2014-02-27 |
4 |
A |
$1.95 |
$110,565 |
D/D |
56,700 |
306,478 |
|
- |
|
| Ozeroff Christopher David |
S.V.P., General Counsel |
• – – |
2014-02-27 |
4 |
A |
$1.95 |
$66,690 |
D/D |
34,200 |
126,737 |
|
- |
|
| Wheeler Patrick M |
Chief Financial Officer |
• – – |
2014-02-27 |
4 |
A |
$1.95 |
$66,690 |
D/D |
34,200 |
109,756 |
|
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2014-02-04 |
4 |
B |
$1.70 |
$1,700,000 |
I/I |
1,000,000 |
3,000,000 |
1.5 |
- |
|
| Mccormack Riley |
10% Owner |
– – • |
2013-09-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000,000 |
|
- |
|
| Wheeler Patrick M |
Chief Financial Officer |
• – – |
2013-09-17 |
4 |
A |
$1.38 |
$103,500 |
D/D |
75,000 |
75,556 |
|
- |
|
| Bristow Michael R |
Pres & CEO |
• • – |
2013-09-17 |
4 |
A |
$1.38 |
$172,500 |
D/D |
125,000 |
249,778 |
|
- |
|
| Ozeroff Christopher David |
S.V.P., General Counsel |
• – – |
2013-09-17 |
4 |
A |
$1.38 |
$103,500 |
D/D |
75,000 |
92,537 |
|
- |
|
| Bristow Michael R |
President and CEO |
• • • |
2013-01-25 |
4 |
B |
$0.47 |
$500,000 |
I/I |
1,069,290 |
1,069,290 |
2.64 |
- |
|
| Bristow Michael R |
President and CEO |
• • – |
2012-12-18 |
4 |
A |
$0.48 |
$250,026 |
I/I |
517,116 |
834,495 |
|
- |
|
240 Records found
|
|
Page 5 of 10 |
|
|
